Latest filing published 07 Mar 2023 for Teva Pharmaceutical Industries Ltd.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Galia Inbar: trading record in brief
All filings by Galia Inbar on record concern Teva Pharmaceutical Industries Ltd. Between 28 February 2022 and 5 March 2023, the trades on record add up to 5 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 7 March 2023, reports an option exercise in Teva Pharmaceutical Industries Ltd. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Galia Inbar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,107 sharesOrdinary SharesSEC:0001209191-23-016708:0
- 4,828 sharesOrdinary SharesSEC:0001209191-23-014438:0
- 5,710 sharesOrdinary SharesSEC:0001209191-22-017051:0
- 4,828 sharesOrdinary SharesSEC:0001209191-22-014470:0
4 of 4 declarations
